01 / 02PERFORM Protocol
PT-141 Performance Pen
PT-141 Bremelanotide — central nervous system libido and performance protocol.
Technical Specifications
Key Attributes
- Central mechanism — acts on hypothalamic MC3R and MC4R, not peripheral vascular pathways
- Supports libido and sexual desire at the neural level
- On-demand subcutaneous administration — discreet pen format
- Distinct from and complementary to vascular-based performance support
- Available through private protocol access in Bangkok — discreet enquiry process
Biohackr.Labs provides product education, protocol guidance, and private client support. Information on this website is not medical advice and does not replace consultation with a licensed healthcare professional.
What's Included
Premium hard case.
Everything included.
Every Biohackr.Labs pen ships in our premium white hard case — holographic logo, foam-fitted interior. Inside: the precision pen, ten individually sealed 31G 8mm micro needles, and all documentation needed to begin your protocol correctly.
Precision pen
Pre-filled, batch quality-controlled pen system ready at your confirmed starting dose.
10× 31G micro needles
31G 8mm individually sealed sterile micro needles. Ten included as standard with every pen.
Protocol card
Starting dose, titration schedule, session guidance, and what to expect — specific to your protocol.
Batch QC documentation
Batch reference, preparation date, and compound specification. Not boilerplate — specific to your order.
Storage & handling guide
Temperature requirements, travel guidance, and handling notes with Bangkok climate context.
WhatsApp support access
Direct channel access throughout your protocol for questions, dose adjustments, and guidance.
Cold-Chain Delivery
Professionally packed
for Bangkok logistics.
Every Biohackr.Labs order is individually sealed, temperature-controlled, and dispatched in protective cold-chain packaging engineered to maintain product integrity from preparation to your door.
2–8°C maintained
Insulated inner liner and cold-pack keep the product in range throughout Bangkok transit.
Discreet outer packaging
Plain kraft outer box — no branding, no product name, no external indication of contents.
Tamper-evident sealing
Every product is individually sealed before dispatch. Integrity is visible at handover.
Step 01
Protocol Overview
“PT-141 Bremelanotide — central nervous system libido and performance protocol.”
The PT-141 Performance Pen delivers 20 mg of PT-141 (Bremelanotide) across 300 precision clicks at 66.7 mcg per click. PT-141 is a melanocortin receptor agonist with a distinct mechanism from vascular-based performance compounds — it acts at the central nervous system level through MC3R and MC4R receptors to support libido and sexual response. As an on-demand compound with a discreet subcutaneous pen format, PT-141 is one of the most requested private access protocols for male performance support in Bangkok and Thailand.
Step 02
Mechanism of Action
PT-141 activates melanocortin receptors (specifically MC3R and MC4R) in the hypothalamus — producing a central nervous system-mediated libido and arousal response. This mechanism is fundamentally different from PDE5 inhibitors (which work peripherally on vascular smooth muscle) — PT-141 acts on the neural pathways that initiate sexual desire and response, rather than on blood flow alone. This makes it effective in contexts where vascular mechanisms are insufficient or where the primary concern is desire rather than mechanical response.
Suggested Use
On-demand subcutaneous administration 1–2 hours before intended use. Begin with 1 click (66.7 mcg) and assess response before increasing. Nausea is a common dose-dependent effect at higher doses — start low.
Who This Protocol Is For
Designed for male clients in Bangkok and Thailand seeking libido and performance support through a central mechanism. Relevant for those who have found vascular-based approaches insufficient, or who are seeking desire-level support rather than purely mechanical response. Private onboarding required.
Storage — Bangkok & Thailand
Refrigerate between 2–8°C. As an on-demand compound, PT-141 should be stored consistently between uses. In Bangkok, do not leave in a hot vehicle or bathroom — return to refrigeration after each use.
Private Access Required
All Biohackr.Labs protocols are guided through private client onboarding. Dosing and administration are confirmed per client before access is granted.
Enquire on WhatsAppThe Compound
What Is PT-141?
Melanocortin Receptor Agonist — Central Mechanism Libido Support
PT-141 (bremelanotide) is a synthetic melanocortin peptide derived from alpha-melanocyte stimulating hormone (α-MSH). It received FDA approval in 2019 as Vyleesi — the first non-hormonal, non-vascular treatment for hypoactive sexual desire disorder (HSDD) in premenopausal women. Its mechanism is entirely distinct from all other sexual health treatments: PT-141 acts on the central nervous system through melanocortin receptors (MC3R and MC4R) in the hypothalamus — activating dopamine-linked desire and arousal pathways in the brain. This neurological mechanism makes it effective in contexts where the problem is desire and central arousal rather than purely vascular response.
Mechanism of Action
How It Works
PT-141 activates MC3R and MC4R receptors in the hypothalamic regions associated with sexual motivation and arousal. These receptors modulate dopaminergic signalling — the neural pathway that generates desire, anticipation, and motivation. Unlike PDE5 inhibitors (Viagra, Cialis), which work peripherally by increasing blood flow to genital tissue, PT-141 initiates the neurological response that precedes and underlies physical arousal. This means it addresses the desire and arousal components that purely vascular drugs do not — making it uniquely useful for men whose primary issue involves reduced desire, psychological component, or incomplete response to PDE5 inhibitors alone.
Evidence Level
FDA-approved for women (Vyleesi) · Phase 3 data in 1,267 participants
Research Landscape
PT-141 has the most robust regulatory evidence base of any compound in the Biohackr.Labs performance range. The RECONNECT trials — two identical Phase 3, randomised, double-blind, placebo-controlled trials in 1,267 premenopausal women — demonstrated significant improvement in sexual desire and reduction in distress from low desire. In men, a 2024 observational study by Goldstein and Goldstein (n=21) showed positive outcomes across desire, arousal, and erectile function. The central mechanism has been validated in multiple studies. FDA approval for Vyleesi provides a level of clinical validation that most peptides lack.
Biohacking & Community Context
PT-141 is the only compound in the Biohackr.Labs range with a direct consumer brand name and FDA approval for its primary use — which gives it unusually high mainstream credibility for a subcutaneous peptide. In the male biohacking and optimization community, PT-141 is used for: men who don't respond adequately to PDE5 inhibitors alone (or at all), men whose primary issue is reduced desire rather than mechanical dysfunction, and as an enhancement tool for men with normal baseline function seeking an amplified response. The Bangkok and Thailand men's health clinic ecosystem — including numerous TRT and optimization clinics — routinely discusses PT-141 as a libido support option. Community-reported onset: typically 60–90 minutes after subcutaneous administration. Side effects most commonly reported: mild nausea at higher doses (managed by starting low), temporary facial flushing.
Protocol Benefits
Reported Benefits & Research Findings
Central Mechanism — Brain Not Vasculature
Acts on MC3R and MC4R receptors in the hypothalamus — activating dopamine-linked desire pathways. Addresses the neurological component that PDE5 inhibitors (Viagra, Cialis) do not touch.
FDA-Validated Mechanism
Bremelanotide received FDA approval as Vyleesi (2019) based on Phase 3 RECONNECT trials in 1,267 participants — the most rigorous regulatory evidence base of any compound in the Biohackr.Labs range.
Complementary to PDE5 Inhibitors
For men with incomplete response to Viagra or Cialis — PT-141's central mechanism addresses desire and arousal while PDE5 inhibitors address vascular response. Used together, they target different parts of the sexual response cycle.
On-Demand Protocol
Administered 60–90 minutes before intended use — enabling as-needed use without daily dosing requirements. The pen format enables precise, low-dose administration with easy dose adjustment.
Desire-Level Support
Particularly relevant for men whose primary concern involves reduced desire, psychological component, or stress-related dysfunction — rather than purely mechanical or vascular issues.
Research Data
Key Findings & Statistics
2019
FDA approval year (Vyleesi)
First non-hormonal, non-vascular FDA-approved treatment for sexual desire disorder — bremelanotide as Vyleesi
FDA approval record
1,267
Phase 3 RECONNECT trial participants
Two identical Phase 3 RCTs in premenopausal women — the largest controlled trial dataset for any melanocortin peptide
RECONNECT Phase 3 trials
60–90 min
Onset time after subcutaneous administration
Community-reported and clinically consistent onset — administration before anticipated activity for optimal timing
Clinical data and community consensus
MC3R/MC4R
Hypothalamic receptor targets
Melanocortin 3 and 4 receptors in the hypothalamus — the neurological basis of the desire and arousal response, distinct from all vascular-based approaches
Pharmacological data
Phase 3 data is from female HSDD studies. Male-specific controlled trial data is limited (n=21 observational, Goldstein 2024). The central mechanism is clinically validated by FDA approval. Off-label use in men is clinically common and mechanistically sound — but male-specific RCT evidence is still limited. Nausea is the most common dose-dependent side effect — starting at 1 click (66.7 mcg) and assessing response before increasing is strongly recommended.
Same Collection
Related PERFORM Protocols
Private Access
Premium imported peptide pens in Bangkok.
Private protocol access · European-sourced · Quality-controlled · Thailand delivery
Enquire About PT-141 Performance Pen